Literature DB >> 24405104

Review of alternative carrier materials for ocular surface reconstruction.

Yaqing Feng1, Maria Borrelli, Stephan Reichl, Stefan Schrader, Gerd Geerling.   

Abstract

Severe ocular surface disorders can result in deficiency of limbal stem cells that is potentially associated with chronic inflammation, impaired vision and even blindness. Advanced stem cells deficiency requires reconstruction of the OS with autologous or allogeneic limbal stem cells. To address such deficiency, a limbal tissue biopsy is taken and limbal cells are expanded on a carrier, which then can be used for OS reconstruction. Human amniotic membrane - currently the most common carrier for transplantation of limbal epithelial stem cells - has the downsides of carrying the risk of disease transmission, limited transparency, variable and unstable quality and low mechanical strength. This article reviews the advantages and disadvantages of the established carrier materials for limbal stem cell transplantation, as well as discussing emerging alternatives, including carriers based on collagen, fibrin, siloxane hydrogel contact lenses, poly(ε-caprolactone), gelatin-chitosan, silk fibroin, human anterior lens capsule, keratin, poly(lactide-co-glycolide), polymethacrylate, hydroxyethylmethacrylate and poly(ethylene glycol) for their potential use in the treatment of limbal stem cell deficiency.

Entities:  

Mesh:

Year:  2014        PMID: 24405104     DOI: 10.3109/02713683.2013.853803

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  20 in total

1.  [Long-term results of autologous transplantation of limbal epithelium cultivated ex vivo for limbal stem cell deficiency].

Authors:  S L Scholz; H Thomasen; K Hestermann; D Dekowski; K-P Steuhl; D Meller
Journal:  Ophthalmologe       Date:  2016-04       Impact factor: 1.059

Review 2.  [Corneal cell therapy-an overview].

Authors:  M Fuest; G Hin-Fai Yam; G Swee-Lim Peh; P Walter; N Plange; J S Mehta
Journal:  Ophthalmologe       Date:  2017-08       Impact factor: 1.059

Review 3.  Concise review: the coming of age of stem cell treatment for corneal surface damage.

Authors:  Charanya Ramachandran; Sayan Basu; Virender S Sangwan; Dorairajan Balasubramanian
Journal:  Stem Cells Transl Med       Date:  2014-09-09       Impact factor: 6.940

4.  [Immunological tolerance of intraocular eyelashes after penetrating corneal injury].

Authors:  C M Schnitzler; M Borrelli; J Menzel-Severing; G Geerling
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

Review 5.  The progress in techniques for culturing human limbal epithelial stem cells.

Authors:  Yan Shen; Qihua Le
Journal:  Hum Cell       Date:  2022-10-01       Impact factor: 4.374

Review 6.  Tissue Engineering the Cornea: The Evolution of RAFT.

Authors:  Hannah J Levis; Alvena K Kureshi; Isobel Massie; Louise Morgan; Amanda J Vernon; Julie T Daniels
Journal:  J Funct Biomater       Date:  2015-01-22

7.  Hydrogels for ocular drug delivery and tissue engineering.

Authors:  Marzieh Fathi; Jaleh Barar; Ayuob Aghanejad; Yadollah Omidi
Journal:  Bioimpacts       Date:  2015-12-28

Review 8.  Use of Mesothelial Cells and Biological Matrices for Tissue Engineering of Simple Epithelium Surrogates.

Authors:  Christian Claude Lachaud; Berta Rodriguez-Campins; Abdelkrim Hmadcha; Bernat Soria
Journal:  Front Bioeng Biotechnol       Date:  2015-08-17

Review 9.  Pre-Clinical Cell-Based Therapy for Limbal Stem Cell Deficiency.

Authors:  Amer Sehic; Øygunn Aass Utheim; Kristoffer Ommundsen; Tor Paaske Utheim
Journal:  J Funct Biomater       Date:  2015-08-28

Review 10.  From discovery to approval of an advanced therapy medicinal product-containing stem cells, in the EU.

Authors:  Graziella Pellegrini; Alessandro Lambiase; Claudio Macaluso; Augusto Pocobelli; Sophie Deng; Gian Maria Cavallini; Roza Esteki; Paolo Rama
Journal:  Regen Med       Date:  2016-04-19       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.